ARCHIVES

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Korsmeyer Wins Bristol-Meyers Squibb Award; Lichter Names President-Elect of ASCO

April 18, 1997

Waxman Introduces NIH Reauthorization, Kennedy To Follow

April 26, 1991

Vanderbilt Wins Lung Cancer SPORE Grant.

May 18, 2001

Review Group Urges Increased Funding For NCI AIDS Drug Discovery Program

December 3, 1999

House Committee Approves $1.9 Bil. NCI Budget

July 31, 1992

Breast Cancer Survivors Report More Severe Fatigue Than Healthy Women

September 28, 2007